Gast ::
| Hauptseite > Publikationsdatenbank > Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant > print |
| Hauptseite > Publikationsdatenbank > Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant > print |
| 001 | 889134 | ||
| 005 | 20221117180421.0 | ||
| 024 | 7 | _ | |a 10.1007/s00259-020-04742-w |2 doi |
| 024 | 7 | _ | |a 0340-6997 |2 ISSN |
| 024 | 7 | _ | |a 1432-105X |2 ISSN |
| 024 | 7 | _ | |a 1619-7070 |2 ISSN |
| 024 | 7 | _ | |a 1619-7089 |2 ISSN |
| 024 | 7 | _ | |a 2128/32230 |2 Handle |
| 024 | 7 | _ | |a 32130450 |2 pmid |
| 024 | 7 | _ | |a WOS:000540800000002 |2 WOS |
| 037 | _ | _ | |a FZJ-2021-00059 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Barthel, Henryk |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant |
| 260 | _ | _ | |a Heidelberg [u.a.] |c 2020 |b Springer-Verl. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1667365520_15986 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The Editorial “Suboptimal Validity of Amyloid Imaging-Based Diagnosis and Management of Alzheimer’s Disease: Why It Is Time to Abandon the Approach” which appeared online ahead of print on October 31, 2019, in the EJNMMI [1] has come to our attention. From our point of view, the topic of amyloid imaging is discussed in a biased and opinionated form in this Editorial. Some facts generally accepted by imaging experts and neuropathologists are questioned or neglected, which may leave the reader with a misleading impression that does not correspond with the current state of knowledge. The EANM Neuroimaging Committee, thus, feels the need to correct this impression in order to allow the reader to differentiate between commonly accepted scientific facts versus individual opinions and matters still unresolved, regarding the topic discussed. For space reasons, we will discuss here only the issues with the greatest risk for misleading interpretation. |
| 536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
| 536 | _ | _ | |a 573 - Neuroimaging (POF3-573) |0 G:(DE-HGF)POF3-573 |c POF3-573 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Arbizu, Javier |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Drzezga, Alexander |0 P:(DE-Juel1)177611 |b 2 |u fzj |
| 700 | 1 | _ | |a Garibotto, Valentina |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Lammertsma, Adriaan A. |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Morbelli, Silvia |0 P:(DE-HGF)0 |b 5 |
| 773 | _ | _ | |a 10.1007/s00259-020-04742-w |g Vol. 47, no. 8, p. 1787 - 1790 |0 PERI:(DE-600)2098375-X |n 8 |p 1787 - 1790 |t European journal of nuclear medicine and molecular imaging |v 47 |y 2020 |x 1619-7089 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/889134/files/Barthel2020_Article_ProvenValidityAndManagementImp.pdf |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:889134 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany |0 I:(DE-HGF)0 |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, University of Navarra Clinic, Pamplona, Spain |0 I:(DE-HGF)0 |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)177611 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany |0 I:(DE-HGF)0 |b 2 |6 P:(DE-Juel1)177611 |
| 910 | 1 | _ | |a German Centre for Neurodegenerative Diseases, Bonn-Cologne, Germany |0 I:(DE-HGF)0 |b 2 |6 P:(DE-Juel1)177611 |
| 910 | 1 | _ | |a Division of Nuclear Medicine and Molecular Imaging, Geneva University, Geneva, Switzerland |0 I:(DE-HGF)0 |b 3 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a VUMC Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands |0 I:(DE-HGF)0 |b 4 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |0 I:(DE-HGF)0 |b 5 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v (Dys-)function and Plasticity |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v Neuroimaging |x 1 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-08-29 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2020-08-29 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NUCL MED MOL I : 2018 |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-08-29 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2020-08-29 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-08-29 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2020-08-29 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NUCL MED MOL I : 2018 |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-08-29 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-2-20090406 |k INM-2 |l Molekulare Organisation des Gehirns |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-2-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|